The global hyperthermia treatment for cancer market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2022-2028). Increase in incidence of different types of cancer and rise in diagnosis rate are the key factors boosting the growth of the market. The most common cancers diagnosed in men are prostate, lung, and colorectal cancers which account for an estimated 43% while for women most common cancers are breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in 2020. Governments in developed countries such as the U.S. raise funds for cancer research to aid in the diagnosis and treatment. Clinical trials are also funded by governments to support companies in developing effective cancer cachexia treatment drugs. For instance, the FY 2019 funds available to the NCI totaled $6.1 billion (includes $400 million in CURES Act funding), reflecting an increase of 3 percent, or $178 million from the previous fiscal year. Under the NCI RPG funding policy for FY 2019. Moreover, in 2019, Cancer Research Society invested more than $145.9 million in cancer research.
To Request a Sample of our Report on Hyperthermia Treatment for Cancer Market: https://www.omrglobal.com/request-sample/hyperthermia-treatment-for-cancer-market
Apart from that, there are some reasons which may interrupt the growth of the hyperthermia treatment market such as, the high cost of the treatment procedure as compared to other cancer procedures as the average cost for hyperthermia treatment in the U.S. is around US$50,000 for each cancer type. Along with this, the treatment with hyperthermia requires special equipment and expertise which is not widely available across the world.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Application
- By Device Type
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Pyrexar Medical Inc., Hydrosun Medizintechnik GmbH, Celsius42 GmbH, Chongqing Haifu medical technology Co. Ltd., Yamamoto Vinita Co., Ltd., Gamida Cell Ltd., and others
A full Report of Hyperthermia Treatment for Cancer Market is Available @ https://www.omrglobal.com/industry-reports/hyperthermia-treatment-for-cancer-market
Hyperthermia Treatment for Cancer Market Segmentation
By Application
- Breast Cancer
- Liver Cancer
- Soft Tissue Sarcoma
- Leukemia
- Head and Neck Tumors
- Prostate Cancer
By Device Type
- Microwave Hyperthermia Device
- Ultrasound Hyperthermia Device
- Infrared Hyperthermia Device
- Short-wave Hyperthermia Device
By End-User
- Hospitals
- Clinics
- Research Institutes
- Cancer Centers
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Andromedic S.r.l.
- Gamida Cell Ltd.
- Hyperthermia Cancer Institute
- Heckle medizintechnik GmbH
- ICHS
- innoMedicus Ltd.
- Oncotherm Kft.
- Omron Corp.
- RAND Corp.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hyperthermia-treatment-for-cancer-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
